These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 719283)

  • 1. Effects of the (+) and (-)-enantiomers of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene on dopamine receptors and on dopamine uptake [proceedings].
    Andrews CD; Davis A; Freeman HS; McDermed JD; Poat JA; Woodruff GN
    Br J Pharmacol; 1978 Nov; 64(3):433P. PubMed ID: 719283
    [No Abstract]   [Full Text] [Related]  

  • 2. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 3. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS; Naylor RJ; Cubeddu LX
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular effects of some N,N-dialkylated derivatives of 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene after central or peripheral administration in rats [proceedings].
    Cannon JG; Hicks PE
    Br J Pharmacol; 1980 Jan; 68(1):188P. PubMed ID: 7357197
    [No Abstract]   [Full Text] [Related]  

  • 6. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine D2-receptor affinities of resolved C1-dimethylated 2-aminotetralins.
    Krotowska A; Nordvall G; Mellin C; Johansson AM; Hacksell U
    Acta Pharm Suec; 1987; 24(4):145-52. PubMed ID: 2964166
    [No Abstract]   [Full Text] [Related]  

  • 8. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors.
    Van der Weide J; Tendijck ME; Tepper PG; De Vries JB; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Feb; 146(2-3):319-26. PubMed ID: 2836210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.
    Tedesco JL; Seeman P; McDermed JD
    Mol Pharmacol; 1979 Sep; 16(2):369-81. PubMed ID: 514252
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN.
    Stoof JC; Horn AS; Mulder AH
    Brain Res; 1980 Aug; 196(1):276-81. PubMed ID: 7397528
    [No Abstract]   [Full Text] [Related]  

  • 12. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor.
    Nichols DE; Jacob JN; Hoffman AJ; Kohli JD; Glock D
    J Med Chem; 1984 Dec; 27(12):1701-5. PubMed ID: 6502600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR of N-alkylated 2-aminotetralins as central dopamine receptor stimulating agents.
    Lien EJ; Nilsson JL
    Acta Pharm Suec; 1983; 20(4):271-6. PubMed ID: 6637518
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
    Zahniser NR; Heidenreich KA; Molinoff PB
    Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behaviour in rats.
    Timmerman W; Rusk IN; Tepper P; Horn AS; Cooper SJ
    Eur J Pharmacol; 1989 Dec; 174(1):107-14. PubMed ID: 2575532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of dopamine agonists.
    Cannon JG
    Annu Rev Pharmacol Toxicol; 1983; 23():103-29. PubMed ID: 6347047
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of 3-PPP to activate dopamine autoreceptors in vitro.
    Sminia P; Mulder AH
    Eur J Pharmacol; 1983 Apr; 89(1-2):183-4. PubMed ID: 6861887
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
    Cross AJ; Crow TJ; Owen F
    Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholaminergic involvement in the biphasic effect of ADATN on temperature in mice.
    Dooley DJ; Namkung MJ; Hungar AA; Horita A; Bowden DM
    Eur J Pharmacol; 1981 May; 71(2-3):269-76. PubMed ID: 7250189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.